Oxygen Equipment Provider Pays $11.4 Million to Resolve False Claims Act Allegations
The Department of Justice announced today that Braden Partners, L.P., doing business as Pacific Pulmonary Services, has agreed to pay $11.4 million to resolve allegations against it and its general partner, Teijin Pharma USA LLC, for violating the False Claims Act by submitting claims for reimbursement to Medicare and other federal healthcare programs for oxygen and related equipment supplied in violation of program rules, and for sleep therapy equipment supplied as part of a cross-referral kickback scheme with sleep clinics.
- Date:April 25, 2017
- Agency:U.S. Department of Justice
- Criminal and Civil Actions